X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA SANOFI INDIA PLETHICO PHARMA/
SANOFI INDIA
 
P/E (TTM) x -1.1 30.5 - View Chart
P/BV x 0.0 5.4 0.3% View Chart
Dividend Yield % 0.0 1.7 -  

Financials

 PLETHICO PHARMA   SANOFI INDIA
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
SANOFI INDIA
Dec-16
PLETHICO PHARMA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs3954,560 8.7%   
Low Rs314,400 0.7%   
Sales per share (Unadj.) Rs604.41,028.5 58.8%  
Earnings per share (Unadj.) Rs32.5129.0 25.2%  
Cash flow per share (Unadj.) Rs51.3186.0 27.6%  
Dividends per share (Unadj.) Rs068.00 0.0%  
Dividend yield (eoy) %01.5 0.0%  
Book value per share (Unadj.) Rs473.6753.6 62.8%  
Shares outstanding (eoy) m34.0823.03 148.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.44.4 8.1%   
Avg P/E ratio x6.634.7 18.9%  
P/CF ratio (eoy) x4.224.1 17.2%  
Price / Book Value ratio x0.55.9 7.6%  
Dividend payout %052.7 0.0%   
Avg Mkt Cap Rs m7,262103,174 7.0%   
No. of employees `000NA3.6 0.0%   
Total wages/salary Rs m1,5963,592 44.4%   
Avg. sales/employee Rs ThNM6,537.7-  
Avg. wages/employee Rs ThNM991.4-  
Avg. net profit/employee Rs ThNM819.8-  
INCOME DATA
Net Sales Rs m20,59823,686 87.0%  
Other income Rs m386708 54.6%   
Total revenues Rs m20,98424,394 86.0%   
Gross profit Rs m2,8185,281 53.4%  
Depreciation Rs m6421,313 48.9%   
Interest Rs m1,59315 10,621.3%   
Profit before tax Rs m9694,661 20.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1381,691 -8.2%   
Profit after tax Rs m1,1072,970 37.3%  
Gross profit margin %13.722.3 61.4%  
Effective tax rate %-14.336.3 -39.4%   
Net profit margin %5.412.5 42.9%  
BALANCE SHEET DATA
Current assets Rs m18,87715,673 120.4%   
Current liabilities Rs m11,8966,678 178.1%   
Net working cap to sales %33.938.0 89.2%  
Current ratio x1.62.3 67.6%  
Inventory Days Days3676 47.3%  
Debtors Days Days19822 886.6%  
Net fixed assets Rs m9,8618,098 121.8%   
Share capital Rs m341230 147.9%   
"Free" reserves Rs m12,33117,088 72.2%   
Net worth Rs m16,13917,356 93.0%   
Long term debt Rs m4,7060-   
Total assets Rs m33,14625,400 130.5%  
Interest coverage x1.6311.7 0.5%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.60.9 66.6%   
Return on assets %8.111.8 69.3%  
Return on equity %6.917.1 40.1%  
Return on capital %12.326.9 45.6%  
Exports to sales %21.424.5 87.3%   
Imports to sales %15.228.0 54.4%   
Exports (fob) Rs m4,4025,801 75.9%   
Imports (cif) Rs m3,1366,627 47.3%   
Fx inflow Rs m4,4027,145 61.6%   
Fx outflow Rs m3,1846,846 46.5%   
Net fx Rs m1,219299 407.5%   
CASH FLOW
From Operations Rs m2,4373,226 75.6%  
From Investments Rs m-6,265-1,555 402.9%  
From Financial Activity Rs m2,490-1,818 -137.0%  
Net Cashflow Rs m-1,337-147 909.6%  

Share Holding

Indian Promoters % 82.7 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 4.3 14.4 29.9%  
FIIs % 5.5 14.6 37.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 10.5 71.4%  
Shareholders   10,665 15,184 70.2%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  WOCKHARDT LTD.  GSK PHARMA  PANACEA BIOTECH  

Compare PLETHICO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 5-YR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS